Press release
Swine Flu Drugs Market to Expand with Significant CAGR by 2025
Swine flu is a respiratory disease originally transmitted from pigs to human beings, and presently even from one person to another. Symptoms of swine flu include vomiting, nausea, sore throat, runny nose, sneezing, coughing, diarrhea, chills, headaches, lethargy, fever, and lack of appetite. Swine flu cases become more prevalent during monsoon and summer seasons. People with weak or compromised immune systems, heart problems, or and diabetics, besides pregnant women and children, are at high-risk of swine flu. The incubation period of swine flu is approximately one day to four days. Diagnosis of swine flu is done in labs through the identification of antigens specifically associated with the H1N1 type A influenza virus. Drugs available for the treatment of swine flu include Tamiflu, Oseltamivir, Relenza, Zanamivir, and Peramivir. However, among swine flu drugs, Peramivir has not been approved by the FDA for the treatment of swine flu.Request to View Brochure of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=41309
Global Swine Flu Drugs Market: Drivers and Restraints
Swine flu virus was for the first time isolated from pigs in the U.S. in 1930 and has been recognized to have caused infections among pigs all over the world. People who are closely associated with pigs, such as pork processors or farmers, tend to get affected with swine flu drugs. In many cases swine flu drugs cross infections that is human flu virus to pigs or swine virus to human beings has remained in the local areas. However, in Mexico, in April 2009, there was an outbreak (pandemic) of swine flu due to infection with the H1N1 virus. The term H1N1 flu was coined by the investigators as it was mainly found infecting human beings and exhibited two main surface antigens, H1 (hem agglutinin type 1) and N1 (neuraminidase type1). Swine flu has been spreading all over the world. Increase in prevalence of swine flu drives the growth of the Swine Flu Drugs Market. In Asia, for instance, India recorded approximately 1,094 deaths in 2017 caused by swine flu, as per a BBC news report. The report also stated that there were a total of 22,186 cases of swine flu testified across India.
Request to View ToC of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=41309
Global Swine Flu Drugs Market: Key Segments
The swine flu drugs market can be segmented on the basis of drug class, dosage form, distribution channel, and region. Based on drug class, the swine flu drugs market can be categorized into neuraminidase inhibitors and inhaled anti-infectives. In terms of dosage form, the swine flu drugs market can be classified into capsule and oral powder inhalation. Based on distribution channel, the swine flu drugs market can be divided into online pharmacies, retail pharmacies, and hospital pharmacies. The hospital pharmacies segment was estimated to dominate the swine flu drugs market in 2016 owing to the wide availability of swine flu drugs in them.
Geographically, the swine flu drugs market can be divided into Latin America, Asia Pacific, Europe, North America, and Middle East & Africa. Asia Pacific accounted for the dominant swine flu drugs market share in 2016 due to increase in prevalence of swine flu in the region. Europe constituted the next leading share of the swine flu drugs market in 2016 owing to rise in infectious diseases among people with certain long-term health conditions, pregnant women, young children, and geriatric population. North America also held a significant share of the swine flu drugs market in 2016, due to increasing prevalence of the swine flu in the region. The swine flu drugs market in Middle East & Africa and Latin America is anticipated to expand during the forecast period.
Global Swine Flu Drugs Market: Key Players
Key players operating in the swine flu drugs market include Gilead Sciences, Inc., Genentech, Inc., F. Hoffmann-La Roche AG, GlaxoSmithKline, and BioCryst Pharmaceuticals, Inc.
View Report -
https://www.transparencymarketresearch.com/swine-flu-drugs-market.html
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Swine Flu Drugs Market to Expand with Significant CAGR by 2025 here
News-ID: 1010450 • Views: …
More Releases from Transparency Market Research

Global Solar Powered Agricultural Dryer Market to Exceed USD 2.4 Billion by 2031 …
The global solar powered agricultural dryer market, valued at US$ 1.6 billion in 2022, is projected to grow at a CAGR of 5.8% from 2023 to 2031, reaching US$ 2.4 billion by the end of 2031. Rising investments in renewable energy, growing awareness of sustainable agricultural practices, and the rapid expansion of the agricultural sector driven by population growth are key factors fueling market growth.
Uncover essential discoveries and trends from…

Technetium-99m Market Forecast 2034: Rising Demand for Diagnostic Imaging and Ra …
The global Technetium‐99m Market was valued at US$ 6.0 Billion in 2023 and is projected to grow at a CAGR of 3.3% from 2024 to 2034, surpassing US$ 8.6 Billion by the end of the forecast period. Advancements in nuclear imaging infrastructure, government-backed healthcare initiatives, and an increasing demand for precise diagnostic procedures are fueling this growth.
Discover essential conclusions and data from our Report in this sample -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=77100
Analysts' Viewpoint
The Technetium‐99m…

Equine Diagnostic Services Market Outlook 2030: From US$ 168 Million in 2019 to …
The global Equine Diagnostic Services Market, valued at approximately US$ 168 million in 2019, is projected to expand at a compound annual growth rate (CAGR) of ~5% from 2020 to 2030, reaching around US$ 280 million by 2030. Equine diagnostic services, encompassing tests like genetic, infectious disease, and imaging diagnostics, are critical for managing horse health in veterinary hospitals, clinics, and mobile settings. The market is driven by increasing equine…

Digital Printing Market to Reach USD 54.4 Billion by 2034, Growing at a CAGR of …
The digital printing market is experiencing strong growth, driven by rapid technological advancements, rising demand for personalized and on-demand printing, and an increasing focus on sustainable solutions. Digital printing allows for the direct transfer of digital files onto a wide range of substrates, offering high-resolution output with greater speed and flexibility. Its adaptability has led to broad adoption across industries such as packaging, textiles, publishing, and advertising-sectors where customization, efficiency,…
More Releases for Swine
Rising Prevalence Of Swine Diseases Fuels Growth In Swine Vaccine Market: Critic …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
Swine Vaccines Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market for swine vaccines has seen robust growth in the past few years. The market size is set to increase from $2.18 billion in 2024 to $2.38 billion in 2025, representing a compound annual growth rate (CAGR) of 8.9%.…
Primary Catalyst Driving Swine Vaccines Market Evolution in 2025: Rising Prevale …
What combination of drivers is leading to accelerated growth in the swine vaccines market?
The surge in swine disease occurrence is predicted to fuel the growth of the swine vaccine market. Swine disease can be described as any deviation from an organism's normal physiological or morphological state, usually coupled with various disease symptoms like pseudorabies, influenza. Swine vaccines are highly effective in battling the escalating swine disease incidents by activating the…
Primary Catalyst Driving Swine Vaccines Market Evolution in 2025: Rising Prevale …
What combination of drivers is leading to accelerated growth in the swine vaccines market?
The surge in swine disease occurrence is predicted to fuel the growth of the swine vaccine market. Swine disease can be described as any deviation from an organism's normal physiological or morphological state, usually coupled with various disease symptoms like pseudorabies, influenza. Swine vaccines are highly effective in battling the escalating swine disease incidents by activating the…
Swine Production Management Software Market Size Analysis by Application, Type, …
USA, New Jersey- According to Market Research Intellect, the global Swine Production Management Software market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
As the cattle sector embraces digital solutions for increasing efficiency and production, the market for swine production management software is expanding quickly. …
Shaping the Swine Artificial Insemination Market in 2025: Combined Technical Sol …
How Big Is the Swine Artificial Insemination Market Expected to Be, and What Will Its Growth Rate Be?_x000D_
Over recent years, the swine artificial insemination market has experienced robust growth. The market, which is projected to increase from $1.86 billion in 2024 to $2.01 billion in 2025, will rise at a compound annual growth rate (CAGR) of 7.9%. Factors driving growth during the historic period include heightened demand for premium-grade pork,…
H1N1 (Swine Influenza) - Drug Pipeline Landscape, 2022
Global Insight Services have recently published a report on H1N1 (Swine Influenza) Pipeline landscape. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration.
The H1N1 flu (swine flu) is primarily caused by the H1N1 strain of the flu (influenza) virus. It is a communicable viral illness causing upper and lower respiratory tract infections.
Swine flu H1N1 infects the cells that line…